PACIRA BIOSCIENCES, INC. Operating Leases, Future Minimum Payments, Remainder of Fiscal Year
PACIRA BIOSCIENCES, INC. (PCRX) had Operating Leases, Future Minimum Payments, Remainder of Fiscal Year of $2.00 million as of 2018-09-30, per its 10-Q filed 2018-11-01.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear · last filed 2018-11-01
- 2018-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $2.00M.
- 2018-06-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $3.93M.
- 2018-03-31: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $5.92M.
- 2017-09-30: Operating Leases, Future Minimum Payments, Remainder of Fiscal Year $2.00M.
| Period end | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year |
|---|---|
| 2018-09-30 | $2.00M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $3.93M 10-Q · filed 2018-08-02 |
| 2018-03-31 | $5.92M 10-Q · filed 2018-05-03 |
| 2017-09-30 | $2.00M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $3.94M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $5.92M 10-Q · filed 2017-05-04 |
| 2016-09-30 | $1.95M 10-Q · filed 2016-11-02 |
| 2016-06-30 | $3.82M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $5.75M 10-Q · filed 2016-05-02 |
| 2015-09-30 | $1.82M 10-Q · filed 2015-10-27 |
| 2015-06-30 | $3.38M 10-Q · filed 2015-07-30 |
| 2015-03-31 | $4.74M 10-Q · filed 2015-04-30 |
| 2014-09-30 | $1.24M 10-Q · filed 2014-10-30 |
| 2014-06-30 | $2.52M 10-Q · filed 2014-07-31 |
| 2014-03-31 | $3.73M 10-Q · filed 2014-05-01 |
| 2013-09-30 | $1.09M 10-Q · filed 2013-10-31 |
| 2013-06-30 | $2.22M 10-Q · filed 2013-08-06 |
| 2013-03-31 | $3.33M 10-Q · filed 2013-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |